Is there a favorable subset of patients with prostate cancer who develop oligometastases?

Author： Singh D. Yi W.S. Brasacchio R.A. Muhs A.G. Smudzin T. Williams J.P. Messing E. Okunieff P.

Publisher： Elsevier

ISSN： 0360-3016

Source： International Journal of Radiation Oncology*Biology*Physics, Vol.58, Iss.1, 2004-01, pp. : 3-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Expectant management with selective delayed intervention for favorable risk prostate cancer

By Klotz L.

Urologic Oncology: Seminars and Original Investigations, Vol. 7, Iss. 5, 2002-09 ,pp. : 175-179

Elsevier

Access to resources Recommend Favorite

WHO International Consultation on Prostate Cancer: A summary

By Albertsen Peter C.

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 155-160

Informa Healthcare

Access to resources Recommend Favorite

Oligometastases confined one organ from colorectal cancer treated by SBRT

By Kang Jin-Kyu Kim Mi-Sook Kim Jin Yoo Seong Cho Chul Yang Kwang Yoo Hyung Seo Young Lee Dong Kang Hae Kim Young Shin Ui-Sup

Clinical and Experimental Metastasis, Vol. 27, Iss. 4, 2010-04 ,pp. : 273-278

Springer Publishing Company

Access to resources Recommend Favorite

Hypofractionated radiotherapy with Tomotherapy for patients with hepatic oligometastases: retrospective analysis of two institutions

By Lee Jong

Clinical and Experimental Metastasis, Vol. 30, Iss. 5, 2013-06 ,pp. : 643-650

Springer Publishing Company

Access to resources Recommend Favorite

Peritoneal Sarcomatosis: Is There a Subset of Patients Who May Benefit from Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy?

By Baratti Dario

Annals of Surgical Oncology, Vol. 17, Iss. 12, 2010-12 ,pp. : 3220-3228

Springer Publishing Company

Access to resources Recommend Favorite